Managing the treatment of NSCLC patients during the COVID-19 pandemic (ES)

Managing the treatment of NSCLC patients during the COVID-19 pandemic (IT)

Managing the treatment of NSCLC patients during the COVID-19 pandemic (DE)

Managing the treatment of NSCLC patients during the COVID-19 pandemic (FR)

Reducing the risk of contracting COVID-19 in patients with NSCLC (IT)

Reducing the risk of contracting COVID-19 in patients with NSCLC (DE)

Reducing the risk of contracting COVID-19 in patients with NSCLC (FR)

Reducing the risk of contracting COVID-19 in patients with NSCLC (ES)

Cabozantinib most effective treatment for metastatic papillary kidney cancer

Oral HIF-2 α inhibitor MK-6482 in patients with advanced clear cell renal cell carcinoma

New tools that can be used in clinical practice to make better decisions for women with early breast cancer

SEMS trial: result of a prospective, multi-institutional phase II clinical trial of surgery in early metastatic seminoma